The article discusses how recent changes made by NAFDAC, Nigeria's drug regulatory agency, are helping to increase the production of medicines in Nigeria and are also drawing in foreign investors. These changes include a new status called ML3 and a policy known as 5+5. Overall, these reforms are seen as positive steps for the local drug industry and the economy.
Don't miss out on breaking stories and in-depth articles.
